DNA Biomed (Israel) Buy Hold or Sell Recommendation
| DNA Stock | ILS 89.60 1.00 1.10% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding DNA Biomed Solns is 'Cautious Hold'. Macroaxis provides DNA Biomed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DNA positions. The advice algorithm takes into account all of DNA Biomed's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting DNA Biomed's buy or sell advice are summarized below:
Real Value 73.29 | Hype Value 89.6 | Market Value 89.6 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell DNA Biomed Solns given historical horizon and risk tolerance towards DNA Biomed. When Macroaxis issues a 'buy' or 'sell' recommendation for DNA Biomed Solns, the advice is generated through an automated system that utilizes algorithms and statistical models.
DNA |
Execute DNA Biomed Buy or Sell Advice
The DNA recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on DNA Biomed Solns. Macroaxis does not own or have any residual interests in DNA Biomed Solns or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute DNA Biomed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
DNA Biomed Trading Alerts and Improvement Suggestions
| DNA Biomed Solns appears to be risky and price may revert if volatility continues | |
| The company has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist DNA Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, DNA Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DNA Biomed Solns sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DNA to invest in growth at high rates of return. When we think about DNA Biomed's use of debt, we should always consider it together with cash and equity. | |
| DNA Biomed Solns has accumulated about 492 K in cash with (2.33 M) of positive cash flow from operations. | |
| Roughly 55.0% of the company shares are held by company insiders |
DNA Biomed Returns Distribution Density
The distribution of DNA Biomed's historical returns is an attempt to chart the uncertainty of DNA Biomed's future price movements. The chart of the probability distribution of DNA Biomed daily returns describes the distribution of returns around its average expected value. We use DNA Biomed Solns price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of DNA Biomed returns is essential to provide solid investment advice for DNA Biomed.
| Mean Return | 0.68 | Value At Risk | -4.25 | Potential Upside | 7.47 | Standard Deviation | 4.34 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of DNA Biomed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
DNA Biomed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DNA Biomed or Electronic Equipment, Instruments & Components sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DNA Biomed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a DNA stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.73 | |
β | Beta against NYSE Composite | -0.98 | |
σ | Overall volatility | 4.51 | |
Ir | Information ratio | 0.14 |
DNA Biomed Volatility Alert
DNA Biomed Solns currently demonstrates below-average downside deviation. It has Information Ratio of 0.14 and Jensen Alpha of 0.73. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure DNA Biomed's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact DNA Biomed's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.DNA Biomed Fundamentals Vs Peers
Comparing DNA Biomed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze DNA Biomed's direct or indirect competition across all of the common fundamentals between DNA Biomed and the related equities. This way, we can detect undervalued stocks with similar characteristics as DNA Biomed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of DNA Biomed's fundamental indicators could also be used in its relative valuation, which is a method of valuing DNA Biomed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare DNA Biomed to competition |
| Fundamentals | DNA Biomed | Peer Average |
| Return On Equity | -0.25 | -0.31 |
| Return On Asset | -0.0375 | -0.14 |
| Current Valuation | 59.57 M | 16.62 B |
| Shares Outstanding | 123.16 M | 571.82 M |
| Shares Owned By Insiders | 54.87 % | 10.09 % |
| Price To Earning | 22.59 X | 28.72 X |
| Price To Book | 0.95 X | 9.51 X |
| EBITDA | 18.42 M | 3.9 B |
| Net Income | 18.37 M | 570.98 M |
| Cash And Equivalents | 492 K | 2.7 B |
| Current Ratio | 0.03 X | 2.16 X |
| Book Value Per Share | 0.79 X | 1.93 K |
| Cash Flow From Operations | (2.33 M) | 971.22 M |
| Earnings Per Share | 0.21 X | 3.12 X |
| Number Of Employees | 11 | 18.84 K |
| Beta | 0.31 | -0.15 |
| Market Capitalization | 86.46 M | 19.03 B |
| Total Asset | 54.62 M | 29.47 B |
| Retained Earnings | (139 M) | 9.33 B |
| Working Capital | 18 M | 1.48 B |
| Current Asset | 26 M | 9.34 B |
| Current Liabilities | 8 M | 7.9 B |
| Z Score | -2.8 | 8.72 |
| Net Asset | 54.62 M |
DNA Biomed Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as DNA . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About DNA Biomed Buy or Sell Advice
When is the right time to buy or sell DNA Biomed Solns? Buying financial instruments such as DNA Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having DNA Biomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Construction Materials Thematic Idea Now
Construction Materials
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out DNA Biomed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the DNA Biomed Solns information on this page should be used as a complementary analysis to other DNA Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for DNA Stock analysis
When running DNA Biomed's price analysis, check to measure DNA Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Biomed is operating at the current time. Most of DNA Biomed's value examination focuses on studying past and present price action to predict the probability of DNA Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Biomed's price. Additionally, you may evaluate how the addition of DNA Biomed to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |